104 related articles for article (PubMed ID: 29950204)
21. Options for treating carbapenem-resistant Enterobacteriaceae.
Rafailidis PI; Falagas ME
Curr Opin Infect Dis; 2014 Dec; 27(6):479-83. PubMed ID: 25259809
[TBL] [Abstract][Full Text] [Related]
22. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
[TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of tigecycline shows that it may be an option for children with severe infections.
Zhu ZY; Yang JF; Ni YH; Ye WF; Wang J; Wu ML
Acta Paediatr; 2016 Oct; 105(10):e480-4. PubMed ID: 27381360
[TBL] [Abstract][Full Text] [Related]
24. Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.
Bucaneve G; Micozzi A; Picardi M; Ballanti S; Cascavilla N; Salutari P; Specchia G; Fanci R; Luppi M; Cudillo L; Cantaffa R; Milone G; Bocchia M; Martinelli G; Offidani M; Chierichini A; Fabbiano F; Quarta G; Primon V; Martino B; Manna A; Zuffa E; Ferrari A; Gentile G; Foà R; Del Favero A
J Clin Oncol; 2014 May; 32(14):1463-71. PubMed ID: 24733807
[TBL] [Abstract][Full Text] [Related]
25. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
Oliva ME; Rekha A; Yellin A; Pasternak J; Campos M; Rose GM; Babinchak T; Ellis-Grosse EJ; Loh E;
BMC Infect Dis; 2005 Oct; 5():88. PubMed ID: 16236177
[TBL] [Abstract][Full Text] [Related]
26. A Snapshot of Co-Resistance to Carbapenems and Tigecycline in Clinical Isolates of Enterobacter cloacae.
Huang LF; Lee CT; Su LH; Chang CL
Microb Drug Resist; 2017 Jan; 23(1):1-7. PubMed ID: 27136494
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014).
Rodloff AC; Dowzicky MJ
Chemotherapy; 2017; 62(1):1-11. PubMed ID: 27216271
[TBL] [Abstract][Full Text] [Related]
28. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and Safety of Tigecycline Compared with Other Broad-Spectrum Antimicrobials in Abdominal Solid Organ Transplant Recipients with Polymicrobial Intraabdominal Infections.
Liebenstein T; Schulz LT; Viesselmann C; Bingen E; Musuuza J; Safdar N; Rose WE
Pharmacotherapy; 2017 Feb; 37(2):151-158. PubMed ID: 27983753
[TBL] [Abstract][Full Text] [Related]
30. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
[TBL] [Abstract][Full Text] [Related]
31. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
32. Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination.
Demiraslan H; Dinc G; Ahmed SS; Elmali F; Metan G; Alp E; Doganay M
J Chemother; 2014 Oct; 26(5):276-81. PubMed ID: 24070112
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
34. Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis.
Seyman D; Berk H; Sepın-Ozen N; Kızılates F; Turk CC; Buyuktuna SA; Inan D
Infect Dis (Lond); 2015; 47(11):783-8. PubMed ID: 26107887
[TBL] [Abstract][Full Text] [Related]
35. Tigecycline: a critical update.
Shakil S; Akram M; Khan AU
J Chemother; 2008 Aug; 20(4):411-9. PubMed ID: 18676218
[TBL] [Abstract][Full Text] [Related]
36. Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies.
Lin S; Zhang C; Ye S
Int J Clin Pharm; 2018 Oct; 40(5):1030-1036. PubMed ID: 30051224
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials.
Gardiner D; Dukart G; Cooper A; Babinchak T
Clin Infect Dis; 2010 Jan; 50(2):229-38. PubMed ID: 20025527
[TBL] [Abstract][Full Text] [Related]
39. Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Gergely Szabo B; Kadar B; Szidonia Lenart K; Dezsenyi B; Kunovszki P; Fried K; Kamotsay K; Nikolova R; Prinz G
Clin Microbiol Infect; 2016 Dec; 22(12):990-995. PubMed ID: 27599690
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of tigecycline in the treatment of nosocomial infection in a hospital in Taiwan.
Wu MT; Chen HY; Ou TY; Kuo LN; Cheng KJ; Lee WS
Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1030-6. PubMed ID: 25345432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
